ArticleVaccines2023

Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical Trial.

Ben Baker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.